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Abstract
Background: Considerable controversy remains about how much oxygen patients should receive during surgery.
The 2016 World Health Organization (WHO) guidelines recommend that intubated patients receive a fractional inspired
oxygen concentration (FIO2) of 0.8 throughout abdominal surgery to reduce the risk of surgical site infection. However,
this recommendation has been widely criticised by anaesthetists and evidence from other clinical contexts has suggested
that giving a high concentration of oxygen might worsen patient outcomes. This retrospective multi-centre observational
study aimed to ascertain intraoperative oxygen administration practice by anaesthetists across parts of the UK.
Methods: Patients undergoing general anaesthesia with an arterial catheter in situ across hospitals affiliated with two
anaesthetic trainee audit networks (PLAN, SPARC) were eligible for inclusion unless undergoing cardiopulmonary bypass.
Demographic and intraoperative oxygenation data, haemoglobin saturation and positive end-expiratory pressure were
retrieved from anaesthetic charts and arterial blood gases (ABGs) over five consecutive weekdays in April and May 2017.
Results: Three hundred seventy-eight patients from 29 hospitals were included. Median age was 66 years, 205 (54.2%)
were male and median ASA grade was 3. One hundred eight (28.6%) were emergency cases. An anticipated difficult
airway or raised BMI was documented preoperatively in 31 (8.2%) and 45 (11.9%) respectively. Respiratory or cardiac
comorbidity was documented in 103 (27%) and 83 (22%) respectively. SpO2 < 96% was documented in 83 (22%) patients,
with 7 (1.9%) patients desaturating < 88% at any point intraoperatively. The intraoperative FIO2 ranged from 0.25 to 1.0,
and median PaO2/FIO2 ratios for the first four arterial blood gases taken in each case were 24.6/0.5, 23.4/0.49, 25.7/0.46
and 25.4/0.47 respectively.
Conclusions: Intraoperative oxygenation currently varies widely. An intraoperative FIO2 of 0.5 currently represents
standard intraoperative practice in the UK, with surgical patients often experiencing moderate levels of hyperoxaemia.
This differs from both WHO’s recommendation of using an FIO2 of 0.8 intraoperatively, and also, the value most previous
interventional oxygen therapy trials have used to represent standard care (typically FIO2 = 0.3). These findings should be
used to aid the design of future intraoperative oxygen studies.
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Background
Approximately 3 million patients undergo general anaes-
thesia in the UK each year and are routinely given sup-
plemental oxygen as part of this procedure (Sury et al.
2014). This makes oxygen one of the most commonly used
drugs during surgery, yet there still remains considerable
uncertainty about how much oxygen patients should receive
during the perioperative period. In November 2016, the
World Health Organization (WHO) recommended that all
intubated patients receive a fractional inspired oxygen
concentration (FIO2) of 0.8 throughout surgery and for
up to 6 h in recovery, as this might reduce patients’ risk of
developing a surgical site infection (SSI) later (Allegranzi
et al. 2016). However, this recommendation has already
been widely criticised by anaesthetists (Ball et al. 2017;
Myles and Kurz 2017), and a Cochrane systematic review
and meta-analysis of 28 trials published in 2015 concluded
that robust evidence is lacking for a beneficial effect of
using a high FIO2 to reduce SSIs (Wetterslev et al. 2015).
In fact, this meta-analysis suggested using a high FIO2
during surgery could increase the risk of adverse events,
including mortality, after long-term findings of the PROXI
study (the largest study included in this review) reported
significantly higher 2-year mortality rate in patients
with abdominal malignancy who received an FIO2 of
0.8 (Wetterslev et al. 2015; Meyhoff et al. 2012).
WHO’s recommendations would also appear to contra-
dict the consensus opinion in other clinical contexts; con-
cerns have been raised about potential harms associated
with hyperoxaemia (defined by others as an arterial oxygen
partial pressure (PaO2) > 13.3 kPa or 100 mmHg (Damiani
et al. 2014a)) after myocardial infarction, after cardiac arrest
and also in critical illness (Farquhar et al. 2009; Damiani et
al. Dell’Anna et al. 2014). Within 15–30 min of onset, FiO2
0.8–1.0 has also been demonstrated to induce atelectasis
(Edmark et al. 2003), systemic vasoconstriction (Reinhart et
al. 1991), coronary vasoconstriction (McNulty et al. 2005)
and (within hours) pulmonary inflammation as well (Davis
et al. 1983). Furthermore, chemical free radicals generated
from oxygen (known as reactive oxygen species, ROS) can
also avidly oxidise proteins, lipids or DNA resulting in cel-
lular oxidative stress—an integral part of the normal surgi-
cal stress response that may also be associated with the
development of multiple post-operative complications
(Kücükakin et al. 2009). A large meta-analysis of over
16,000 patients concluded that high-quality evidence now
shows liberal oxygen therapy in acutely ill adults increases
mortality without improving other patient-important out-
comes, suggesting that supplemental oxygen administra-
tion might become unfavourable above an SpO2 range of
94–98% (Chu et al. 2018).
Currently, there is limited data describing the intraop-
erative oxygen administration practices of UK anaesthe-
tists. Given the current controversy surrounding WHO’s
recommendations for perioperative oxygen use, the aim
of this multi-centre observational study was to characterise
practice as regards the administration of oxygen to patients
undergoing major surgery and to describe intraoperative
arterial oxygenation during general anaesthesia.
Methods
A multi-centre retrospective observational study was con-
ducted across 29 hospitals in London and parts of the
South Coast of England affiliated with two trainee-led
research networks: PLAN (Pan-London Perioperative
Audit and Research Network—http://www.uk-plan.net)
or SPARC (South Coast Perioperative Audit and Research
Collaborative—http://wessex-sparc.com). The project was
confirmed to be a clinical service evaluation by the Royal
Free London and Southampton NHS Trust Clinical
Governance departments, and research ethics committee
approval and individual patient consent were not required.
Appropriate approval was secured from the clinical
governance department in each participating hospital.
Patients aged 18 years and over undergoing general
anaesthesia for elective or emergency operations necessi-
tating the insertion of an arterial cannula and subsequent
arterial blood gas (ABG) monitoring were included.
Patients receiving cardiopulmonary bypass were excluded
(as during bypass, oxygen administration is often not con-
trolled by the anaesthetist).
Data collection took place over five consecutive weekdays
in April and May 2017; flexibility in the data collection
window ensured maximum compliance locally. Anaesthetic
trainees not involved in the clinical care of the patients
collected data from the anaesthetic record. Patients were
identified and assessed for inclusion daily from depart-
mental operating lists. A retrospective review of anaesthetic
charts and arterial blood gases was performed after the
patients in question had been moved from theatre to the
recovery area, ward or intensive care unit. Oxygenation data
(including intraoperative SpO2, FIO2 and PaO2 values),
together with intraoperative positive end-expiratory
pressure (PEEP) values and patient demographics, were
collected using paper case report forms, held securely
and treated as strictly confidential according to NHS
policies.
Statistics were calculated using IBM SPSS Statistics,
Version 24.0, Armonk, NY: IBM Corp. Data were exam-
ined for normality using the Shapiro-Wilk test. Unpaired
data were compared using the Wilcoxon-Mann-Whitney
U test and Kruskal-Wallis tests. Correlation was tested
with Spearman’s rank correlation coefficient. All tests
were two-tailed, and significance was taken as p < 0.05.
Continuous data were presented as median (IQR) and
categorical data as number (percentage). Cumulative
oxygen dose was determined in patients for whom more
than one ABG was recorded, by calculating the area
Morkane et al. Perioperative Medicine  (2018) 7:17 Page 2 of 7
under the curve between the times of the first and final
ABGs, in a plot of recorded PaO2 as a function of time,
with T0 equal to the time of the initial ABG.
Results
Data from 378 anaesthetic cases were contributed from
29 hospitals across London and Wessex. Results were
reported from 17 (58.6%) district general hospitals (DGHs),
8 (27.6%) teaching hospitals and 4 (13.8%) speciality
hospitals. Paper-based anaesthetic records were used in
334 (88.4%) cases, with electronic records contributed
by three sites. The median patient age was 66 years
(IQR 52–74). Patient demographics and clinical details
along with operation characteristics are shown in
Table 1.
Surgical duration ranged from 1 to 13 h with a median
of 4 h. Estimated blood loss was > 1000 ml in 31 (8.2%)
patients. In total, 824 arterial blood gases were analysed.
The number of ABGs recorded for each patient ranged
from 1 to 13, with a median of 2. SpO2 of < 96% was
documented in 83 (22%) patients, with only 7 (1.9%)
patients desaturating to < 88% at any point during the
operation. Table 2 illustrates values for SpO2, PaO2 and
haemoglobin concentration in the first five ABGs for
each patient.
Table 1 Patient and operation characteristics
Variable Patient/surgical characteristics number (%)
Gender Male 205 (54.2%)
Female 173 (45.8%)
ASA classification 1 17 (4.5%)
2 158 (41.8%)
3 153 (40.5%)
4 34 (8.99%)
5 5 (1.3%)
Not recorded 11 (2.9%)
Documented respiratory disease Asthma 37 (9.8%)
COPD 31 (8.2%)
Obstructive sleep apnoea 10 (2.6%)
Other 25 (6.6%)
Documented cardiovascular disease Hypertension 145 (38.4%)
Ischaemic heart disease 49 (13%)
Atrial fibrillation 31 (8.2%)
Congestive cardiac failure 16 (4.2%)
Valvular disease 18 (4.8%)
Other 34 (9%)
National Confidential Enquiry into Patient
Outcome and Death (NCEPOD) classification
Elective 270 (71.4%)
Urgent/immediate/expedited 108 (28.6%)
Surgical specialty Upper gastrointestinal/colorectal/general/breast 111 (29.4%)
Urology/renal (including renal transplantation) 34 (9%)
Vascular 37 (9.8%)
Orthopaedics/spinal 29 (7.7%)
Hepatopancreaticobiliary/liver transplant
(including liver transplantation)
32 (8.5%)
Ear nose and throat/maxillofacial 17 (4.5%)
Neurosurgery 45 (11.9%)
Gynaecology 23 (6.1%)
Cardiothoracic 23 (6.1%)
Plastics 2 (0.5%)
Other 25 (6.6%)
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The median PaO2 and FIO2 for all analysed ABGs
combined were 24.7 kPa (IQR 17.9–30.8) and 0.50 kPa
(IQR 0.41–0.55) respectively. There was no significant
difference in the PaO2 recorded across sequential ABGs
(p = 0.23). Median FIO2 was also consistent across
sequential ABGs, although the variation about the median
decreased by the fifth ABG (Fig. 1). Figure 1b demon-
strates marked spread of data and a weak positive
association between measured PaO2 and FIO2 (r = 0.22,
p ≤ 0.001). Supraphysiological values for PaO2 (defined
as > 13.3 kPa) were observed in 734 (89%) ABGs. Of
the 769 ABGs for which the corresponding FIO2 was
recorded, an FIO2 ≥ 0.8 was administered on 32 (4.2%)
occasions. Of these 32 occasions, 20 (62.5%) were at
the time of taking the baseline arterial gas, closest to
induction of anaesthesia.
The median cumulative oxygen dose, calculated for
those patients for whom at least two ABGs were docu-
mented (n = 223), was 3824 kPa min (IQR 2121–6923)
over a median time of 159 min (IQR 91–291). The
administration of 13.3 kPa O2 over the same time
period would have resulted in a median cumulative
oxygen dose of 2088 kPa. Representative traces of the
cumulative oxygen dose administered to four individual
patients are illustrated in Fig. 2.
Positive end-expiratory pressure (PEEP) was recorded in
287 (75.9%) of cases, and the median PEEP administered
was 5 cmH2O (range 0–12). A PEEP of 4, 5 or 6 cmH2O
was administered in 207 (72.1%) of cases where PEEP was
recorded. A change in the level of PEEP administered was
documented during only 28 cases.
Discussion
These results demonstrate that the amount of oxygen
anaesthetists administer to adult patients undergoing
major surgery in the UK currently varies widely—the
recorded FIO2 ranged from 0.25 to 1.0 throughout surgery.
In many patients, FIO2 was nearer 0.5 for the duration of
surgery, resulting in PaO2 values of approximately 25 kPa
throughout.
An FIO2 of 0.5 is much higher than “standard” therapy
used for control groups (where FIO2 is typically 0.3) in
previous studies of “high” versus “standard” oxygen therapy
(Wetterslev et al. 2015) and also considerably less than the
WHO now recommends (Allegranzi et al. 2016). Interest-
ingly, the findings from this UK-based sample exactly
match values recently reported as representing current
practice in the Cleveland Clinic, USA (Kurz et al. 2018).
These results are also similar to the LAS VEGAS study (a
prospective cross-sectional study of 9808 patients from 29
different countries) where half of all patients received an
FIO2 between 0.4 and 0.6 and one third between 0.6 and
Table 2 Oxygenation and haemoglobin values from the first five sequential arterial blood gas samples
ABG number Median FIO2 (IQR) Median PaO2 in kPa (IQR) Median P:F ratio in kPa (IQR) Median haemoglobin concentration g/l (IQR)
1 (n = 378) 0.5 (0.45–0.59) 24.5 (16.7–32.6) 51.2 (36.9–66.0) 113 (100–126)
2 (n = 227) 0.49 (0.4–0.54) 23.4 (17.4–29.5) 50.6 (38.1–62.9) 111 (100–124)
3 (n = 116) 0.46 (0.4–0.51) 25.7 (19.6–29.2) 54.5 (43.3–65.2) 108 (99–119)
4 (n = 51) 0.47 (0.4–0.5) 25.4 (20.7–30.8) 57.2 (43.9–71.1) 111 (93–153)
5 (n = 24) 0.49 (0.3–0.51) 26.3 (23.4–29.3) 58.6 (45.3–66.7) 99 (93–116)
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Fig. 1 Intraoperative oxygenation illustrated by a box and whisker
plot illustrating FIO2 administered over first five ABGs. Boxes are
drawn between 25th and 75th percentiles with the median
represented by a line and the whiskers indicating the minimum and
maximum values. b Scatter plot and linear relationship between
FIO2 and PaO2 for each ABG. The continuous line represents the
relationship between partial pressure of arterial oxygen recorded
and the fraction of inspired oxygen delivered (r = 0.22, p ≤ 0.001)
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0.8 Rogerson et al. (2017). LAS VEGAS also reported a
median PEEP of 5 cmH2O (the value in > 50% cases where
PEEP was recorded in this study) suggesting this also
represents the current “standard” of practice Rogerson et
al. (2017).
In many other clinical contexts, including on the critical
care unit, PaO2 values around 25 kPa would likely be
classed as moderate hyperoxia rather than normoxia
(Damiani et al. 2014a). However, median intraoperative
PaO2 values of approximately 25 kPa are consistent with
an earlier single UK centre pilot study carried out by our
group, reporting a mean PaO2 of 24.4 kPa in 75 surgical
patients over a 6-week period (Martin and Grocott 2015),
and observational data also suggests that current practice
still favours hyperoxaemia in critically ill patients (de
Jonge et al. 2008; Eastwood et al. 2012).
Intraoperative hyperoxaemia may be a consequence of
several factors. Firstly, up to now, evidence associating
hyperoxia under anaesthesia with harm has been relatively
limited. However, high intraoperative FIO2 has been retro-
spectively associated in a dose-dependent manner with
increased post-operative respiratory complications and
with increased mortality (Staehr-Rye et al. 2017); the
PROXI study demonstrated a higher 2-year mortality in
patients with abdominal malignancy who received an
FIO2 of 0.8; and similarly, in 2018, a trial of over 5000
patients reported that using an FIO2 of 0.8 intraoperatively
instead of 0.3 did not alter SSI rates but did double 30-day
mortality rates (p = 0.08) (Kurz et al. 2018). Secondly,
continuous monitoring of arterial oxygenation during
general anaesthesia occurs mainly via pulse oximetry
with a scale that stops at 100%. New technology may
allow non-invasive measurement of surrogate markers
of PaO2 in the future (e.g. the oxygen reserve index
(Applegate et al. 2016)), but the use of these devices is
currently limited. The duration of oxygen exposure
may also possibly affect the outcomes, yet this has often
not been considered or reported in clinical trials previously.
The method of determining cumulative oxygen dose dem-
onstrated here could represent a more relevant measure
for use in future outcome studies.
Strengths and limitations
This study characterises how anaesthetists in the UK
currently use oxygen during a mixed selection of major
surgery and in a large number of different hospitals. The
biggest limitation to these findings is that corresponding
clinical outcomes could not be collected. This should be a
focus of future prospective research studies, and although
this study was never designed to collect outcome data
itself, our findings that FIO2 of 0.5 currently represents
“standard care” (and not 0.3 as used by most trials to date)
should be considered in the design of future trials. Area
under the curve analysis could only be performed between
times of arterial blood gas sampling, which could not be
specified due to the retrospective and observational study
design, and consequently, our data may represent under-
estimates of total cumulative oxygen doses as FIO2 is
often increased at the start and end of anaesthesia to
prepare for intubation and extubation. Because of the way
most recruiting hospitals routinely document anaesthesia,
the majority of data were collected from paper anaesthetic
records. Previous studies have suggested a paper anaes-
thetic chart is not always the most accurate record of
Fig. 2 Sample traces demonstrating of cumulative oxygen dose for four individual patients. The solid line represents the actual PaO2 recorded in
successive blood gases, whilst the dashed line represents the physiological upper limit (13.3 kPa). Area under the curve (shaded) was calculated
between the times of the first and final ABGs
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intraoperative events (Devitt et al. 1999); however, in our
study, findings from centres using paper charts were still
very similar to those using electronic recording systems.
In order to record PaO2 values, we included patients
undergoing procedures necessitating arterial line insertion;
implying our findings might only be applicable to those in
whom invasive monitoring was deemed necessary by the
anaesthetist, either due to patient or operative factors.
However, despite all of these limitations, our findings cor-
roborated reports of current practice in other countries
exactly (Kurz et al. 2018).
Conclusions
Anaesthetists are currently faced with an international
recommendation on the intraoperative administration of
oxygen that conflicts with the majority of evidence from
other clinical contexts. It is perhaps not surprising therefore
that the amount of oxygen administered to patients
undergoing general anaesthesia in the UK varies widely.
The administration of an FIO2 of 0.5 appears to be the
current standard of care for UK-based anaesthetists,
which is often associated with moderate levels of hyperox-
aemia intraoperatively. These findings are very similar to
the reports from other countries and need to be considered
in the design of any future studies investigating the
potential impact intraoperative oxygen therapy may have
on surgical patients’ outcomes.
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